SCHEMBL30744137

SCHEMBL30744137

COc1ccc(/C=C/C(=O)c2cccc(Cl)c2O)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.67
MAOB P27338 5/20 0.67
CYP2C19 P33261 2/20 0.67
MAOA P21397 2/20 0.67
CYP2D6 P10635 1/20 0.67
CYP2C9 P11712 1/20 0.67
CASP3 P42574 1/20 0.67
SENP8 Q96LD8 1/20 0.67
SENP7 Q9BQF6 1/20 0.67
SENP6 Q9GZR1 1/20 0.67
ABCG2 Q9UNQ0 5/20 0.62
ACHE P22303 1/20 0.60
BACE1 P56817 1/20 0.60
MEN1 O00255 3/20 0.59
MAPK1 P28482 3/20 0.59
KMT2A Q03164 3/20 0.59
CYP3A4 P08684 3/20 0.59
LMNA P02545 2/20 0.59
SMN1; SMN2 Q16637 2/20 0.59
APP P05067 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5138843 1.00 MAPT (0.67) MAPTMAOBCYP2C19MAOACYP2D6
SCHEMBL5138841 1.00 MAPT (0.67) MAPTMAOBCYP2C19MAOACYP2D6
SCHEMBL14692575 0.87 MAOB (0.72) MAPTMAOBCYP2C19MAOACYP2D6
SCHEMBL9420986 0.87 MAOB (0.72) MAPTMAOBCYP2C19MAOACYP2D6
SCHEMBL5085503 0.85 MAPT (0.64) MAPTMAOBMAOAABCG2MEN1
SCHEMBL5085506 0.85 MAPT (0.64) MAPTMAOBMAOAABCG2MEN1
SCHEMBL5138124 0.83 MAPT (0.63) MAPTMAOBCYP2C19MAOAABCG2
SCHEMBL5138125 0.83 MAPT (0.63) MAPTMAOBCYP2C19MAOAABCG2
SCHEMBL30504733 0.83 F3 (0.71) MAPTMAOBCYP2C19MAOACYP2D6
SCHEMBL5138954 0.83 KDM4E (0.70) MAPTMAOBCYP2C19MAOACYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112601743-B Flavone compounds for the treatment and prevention of hepatitis b virus diseases 豪夫迈·罗氏有限公司 2023-12-19 CN disclosed